Food Allergy Advocacy Sends Petition with First 20,000 Signatures to FDA and Congress Demanding Approval of Nasal Epinephrine
NEW YORK, Oct. 12, 2023 /PRNewswire/ -- SnackSafely.com — a leading food allergy advocacy established in 2011 — sent a petition with over 20,000 signatures to the FDA and oversight committees in Congress, demanding approval of nasal epinephrine for use in anaphylactic emergencies.
- NEW YORK, Oct. 12, 2023 /PRNewswire/ -- SnackSafely.com — a leading food allergy advocacy established in 2011 — sent a petition with over 20,000 signatures to the FDA and oversight committees in Congress, demanding approval of nasal epinephrine for use in anaphylactic emergencies.
- Anaphylaxis is a life-threatening allergic reaction to a food, drug, insect venom, or environmental substance.
- Epinephrine is the only drug that can halt and reverse the progression of anaphylaxis, but it must be administered promptly to be effective.
- Furthermore, the FDA's own advisory panel voted 17-5 to approve a nasal epinephrine candidate for children and 16-6 for adults in May of 2023.